enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. The Top 5 Ozempic Alternatives - AOL

   www.aol.com/top-5-ozempic-alternatives-194700772...

   Here are 5 Ozempic alternatives that just may work, depending on what you're using it for. What is Ozempic? Released in 2017, Ozempic was originally created as a treatment for type 2 diabetes .

3. 15 Alternatives to Ozempic for Weight Loss - AOL

   www.aol.com/15-alternatives-ozempic-weight-loss...

   A 2020 meta-analysis of 21 trials found that metformin treatment could reduce BMI by one unit. Beyond weight loss, there are more metformin benefits, including anti-tumor effects, and reducing the ...

4. Is oral semaglutide a promising alternative in treating ... - AOL

   www.aol.com/lifestyle/oral-semaglutide-promising...

   A new clinical trial in Italy investigates the efficacy of oral semaglutide. Semaglutide and other GLP-1 agonist drugs to treat diabetes, cardiovascular health, and weight loss, are most widely ...

5. Semaglutide - Wikipedia

   en.wikipedia.org/wiki/Semaglutide

   Semaglutide is an anti-diabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. [ 23 ] [ 24 ] [ 25 ] It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain .

6. Hyperinsulinemic hypoglycemia - Wikipedia

   en.wikipedia.org/wiki/Hyperinsulinemic_hypoglycemia

   Prevention of further episodes consists of maintaining balance between insulin, food, and exercise. Management of hypoglycemia due to treatment of type 2 diabetes is similar, and the dose of the oral hypoglycemic agent may need to be reduced. Reversal and prevention of hypoglycemia is a major aspect of the management of type 1 diabetes.

7. SGLT2 inhibitor - Wikipedia

   en.wikipedia.org/wiki/SGLT2_inhibitor

   SGLT2 inhibitors are used in the treatment of type 2 diabetes. Apart from blood sugar control, gliflozins have been shown to provide significant cardiovascular benefit in people with type 2 diabetes. [2] [3] As of 2014, several medications of this class had been approved or were under development. [4]